Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Bone Marrow Transplantation
|
September 15, 2010
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (high-dose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination
K Jordan, F Jahn, P Jahn, et al.
AJNR. American Journal of Neuroradiology
|
May 1, 1983
Computed tomography of the anteverted internal auditory canal
A J Silver, A F Jahn, P Sane, et al.
Klinische Padiatrie
|
October 30, 2013
Treatment of adolescents and young adults (AYA) with cancer in a multidisciplinary setting: on the way to a highly specialized AYA unit
T Bernig, F Jahn, S Witkowsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 28, 2020
Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines<sup>☆</sup>
M E Lacouture, V Sibaud, P A Gerber, et al.
Journal of Oral Rehabilitation
|
October 6, 2005
Effects of prosthetic treatment for shortened dental arches on oral health-related quality of life, self-reports of pain and jaw disability: results from the pilot-phase of a randomized multicentre trial
S Wolfart, G Heydecke, R G Luthardt, et al.
Clinical Oral Investigations
|
May 18, 2013
The randomized shortened dental arch study: oral health-related quality of life
S Wolfart, F Müller, J Gerß, et al.
Clinical Oral Investigations
|
June 27, 2012
The randomized shortened dental arch study: tooth loss over five years
M H Walter, W Hannak, M Kern, et al.
Journal of Dental Research
|
April 20, 2010
The randomized shortened dental arch study: tooth loss
M H Walter, A Weber, B Marré, et al.
ESMO Open
|
March 8, 2024
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
J Herrstedt, R Clark-Snow, C H Ruhlmann, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Bone Marrow Transplantation
|
September 15, 2010
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (high-dose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination
K Jordan, F Jahn, P Jahn, et al.
AJNR. American Journal of Neuroradiology
|
May 1, 1983
Computed tomography of the anteverted internal auditory canal
A J Silver, A F Jahn, P Sane, et al.
Klinische Padiatrie
|
October 30, 2013
Treatment of adolescents and young adults (AYA) with cancer in a multidisciplinary setting: on the way to a highly specialized AYA unit
T Bernig, F Jahn, S Witkowsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 28, 2020
Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines<sup>☆</sup>
M E Lacouture, V Sibaud, P A Gerber, et al.
Journal of Oral Rehabilitation
|
October 6, 2005
Effects of prosthetic treatment for shortened dental arches on oral health-related quality of life, self-reports of pain and jaw disability: results from the pilot-phase of a randomized multicentre trial
S Wolfart, G Heydecke, R G Luthardt, et al.
Clinical Oral Investigations
|
May 18, 2013
The randomized shortened dental arch study: oral health-related quality of life
S Wolfart, F Müller, J Gerß, et al.
Clinical Oral Investigations
|
June 27, 2012
The randomized shortened dental arch study: tooth loss over five years
M H Walter, W Hannak, M Kern, et al.
Journal of Dental Research
|
April 20, 2010
The randomized shortened dental arch study: tooth loss
M H Walter, A Weber, B Marré, et al.
ESMO Open
|
March 8, 2024
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
J Herrstedt, R Clark-Snow, C H Ruhlmann, et al.
Page
of 9